In particular, 20-40% of SMS patients have heart defects, and we speculate that LLGL1 may be of importance in this syndrome as, to-date, no candidate gene has been identified that may underlie these cardiac defects (Onesimo et al., 2021). Here, LLGL1 is linked to Smith-Magenis syndrome.